About
Technology
Issues
FAQ
Links
Official Page
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.